Lugano, Switzerland, 25 August 2020 - Recommendations on the use of next-generation sequencing (NGS) for patients with metastatic cancers are being launched today [25 August] by the European Society ...
Integrating plasma next-generation sequencing (NGS) alongside tissue testing when determining lung cancer diagnosis may improve outcomes for patients. Carrying out plasma next-generation sequencing ...
Circulating tumor DNA as a prognostic biomarker for long-term survival in de-novo oligometastatic non-small cell lung cancer. The prevalence and outcomes of hypercalcemia in Black American patients ...
The investigation of multiple molecular targets with next-generation sequencing (NGS) has entered clinical practice in oncology, yielding to a paradigm shift from the histology-centric approach to the ...
Integrating NGS with Olink’s PEA (Proximity Extension Assay) technology, Olink® Reveal sets a new benchmark in high-plex proteomics. Making Proteomics accessible to all labs Proteomics is essential in ...
A method developed at the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB enables bacterial, viral, fungal, or parasitic pathogens in sepsis patients to be identified much ...
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, today released cost analysis results and health economic ...
Next-generation sequencing (NGS) can aid law enforcement in solving decades-old cases and provide justice for victims. There is a higher chance of finding a perpetrator when NGS data is used, as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback